Important Numbers
Ajman Campus
+971 6 748 2222 Admission & Registration +971 6 748 2222
Finance Department +9716705 6874 Housing +971 6 7056635
Transportation +971 6 7056912
Medical Clinic +971 6 7056294, +971 6 7056773
Location Map
-
Mohammad Anas Shamsi
- Full-Time Research Associate
- Ext: 5282
Dr. Mohammad Anas Shamsi is a Full Time Research Associate at Center for Medical and Bio-Allied Health Sciences Research. His research area is Structure based Drug Design and Discovery. He is working in the most exciting areas of medicinal chemistry with special focus to the structure-based drug design and discovery, targeting the discovery of new drugs for the treatment of Cancer and Alzheimer's and related neurodegenerative diseases.
Education
- PhD, Aligarh Muslim University, India, 2017
- M.Sc (Biochem), Aligarh Muslim University, India, 2013
- B.Sc (Biochem), Aligarh Muslim University, India, 2011
PhD, Aligarh Muslim University, India, 2017
M.Sc (Biochem), Aligarh Muslim University, India, 2013
B.Sc (Biochem), Aligarh Muslim University, India, 2011
Experience
- Full Time Research Associate at Ajman University
- D.S. Kothari Postdoctoral Fellow, Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, India, 2 years 9 months
- National Postdoctoral Fellow, Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, India, 2 years
Full Time Research Associate at Ajman University
D.S. Kothari Postdoctoral Fellow, Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, India, 2 years 9 months
National Postdoctoral Fellow, Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, India, 2 years
Research
- Structure based Drug Design and Discovery
- Protein Biochemistry
- Protein folding and dynamics
- Neurodegenerative Diseases
- Protein aggregation and glycation
- Protein-Drug Interactions
- Cancer Therapeutics
Structure based Drug Design and Discovery
Protein Biochemistry
Protein folding and dynamics
Neurodegenerative Diseases
Protein aggregation and glycation
Protein-Drug Interactions
Cancer Therapeutics
Conference Presentation
- Repurposing Drugs for Bruton's tyrosine kinase inhibition at MONASH INITIATE 2023 held at Monash University, Malaysia.
- Oral Presentation entitled “ Rosmarinic acid exhibits Anticancer effects via MARK4 inhibition at Cancer Research and Oncology” held at Dubai, UAE on 14-15 November 2022.
- Oral presentation entitled “Targeting MARK by rosmarinic acid: Implications in anticancer therapeutics” at National Science day 2020 at Jamia Millia Islamia, New Delhi, India
- Poster Presentation at International conference “ICBAB-2019” entitled “Spectroscopic, calorimetric and molecular docking insight into the interaction of Alzheimer's drug donepezil with human transferrin: implications of Alzheimer's drug” at ICBAB-2019.
- Poster presentation entitled “Global transition of human serum albumin to prefibrillar aggregates in the presence of temsirolimus” at Frontiers in Cancer Science-2017 held at Singapore
- Poster presentation entitled “Probing the interaction of anticancer drug temsirolimus with human serum albumin: Molecular docking and spectroscopic approach” at ISBOC-11 held at University of Konstanz, Germany from 27-29 September, 2017.
- Oral presentation “Temsirolimus induced reversion of cancerous renal cystatin to normal form in rats” in PHOENIX 2017 at Mangalore, India.
- Poster Presentation “Structural transition of kidney cystatin induced by silicon dioxide nanoparticles: An implication for renal diseases” at National Seminar on Recent Advances in Environmental Toxicology at Jamia Millia Islamia, New Delhi (2017).
- Oral presentation “Structural transition of kidney cystatin in dimethylnitrosaimne induced renal cancer in rats: Insight into renal cancer treatment ” in “7th International Conference on Biotechnology, Bio Informatics, Bio Medical Sciences and Stem Cell Applications (B3SC), Singapore (2016)”.
- Poster presentation “In vitro toxicity assessment of silica nanoparticles on buffalo kidney cystatin: biomarker for kidney damage” at Emerging Trends in Biomedical Sciences, AMU, Aligarh, India (2016).
- Oral Presentation “In vitro toxicity assessment of silica nanoparticles on buffalo kidney cystatin: biomarker for kidney damage” at Nano Today 2015 in Dubai, UAE.
Repurposing Drugs for Bruton's tyrosine kinase inhibition at MONASH INITIATE 2023 held at Monash University, Malaysia.
Oral Presentation entitled “ Rosmarinic acid exhibits Anticancer effects via MARK4 inhibition at Cancer Research and Oncology” held at Dubai, UAE on 14-15 November 2022.
Oral presentation entitled “Targeting MARK by rosmarinic acid: Implications in anticancer therapeutics” at National Science day 2020 at Jamia Millia Islamia, New Delhi, India
Poster Presentation at International conference “ICBAB-2019” entitled “Spectroscopic, calorimetric and molecular docking insight into the interaction of Alzheimer's drug donepezil with human transferrin: implications of Alzheimer's drug” at ICBAB-2019.
Poster presentation entitled “Global transition of human serum albumin to prefibrillar aggregates in the presence of temsirolimus” at Frontiers in Cancer Science-2017 held at Singapore
Poster presentation entitled “Probing the interaction of anticancer drug temsirolimus with human serum albumin: Molecular docking and spectroscopic approach” at ISBOC-11 held at University of Konstanz, Germany from 27-29 September, 2017.
Oral presentation “Temsirolimus induced reversion of cancerous renal cystatin to normal form in rats” in PHOENIX 2017 at Mangalore, India.
Poster Presentation “Structural transition of kidney cystatin induced by silicon dioxide nanoparticles: An implication for renal diseases” at National Seminar on Recent Advances in Environmental Toxicology at Jamia Millia Islamia, New Delhi (2017).
Oral presentation “Structural transition of kidney cystatin in dimethylnitrosaimne induced renal cancer in rats: Insight into renal cancer treatment ” in “7th International Conference on Biotechnology, Bio Informatics, Bio Medical Sciences and Stem Cell Applications (B3SC), Singapore (2016)”.
Poster presentation “In vitro toxicity assessment of silica nanoparticles on buffalo kidney cystatin: biomarker for kidney damage” at Emerging Trends in Biomedical Sciences, AMU, Aligarh, India (2016).
Oral Presentation “In vitro toxicity assessment of silica nanoparticles on buffalo kidney cystatin: biomarker for kidney damage” at Nano Today 2015 in Dubai, UAE.
Memberships, Awards and Honors
- Member of Royal Society of Biology, London
- Collaborative Member of Global Burden of Disease
- Lifetime member of Global research and Development Services
- Bioinformatics and Drug Design Society Member
- Dr. D.S. Kothari Postdoctoral Award by UGC, Govt. of India
- National Postdoctoral Award by DST-SERB, Govt. of India
- Young Research Scientist Award by GRDS
- Best Paper Presenter Award at 7th International Conference on Biotechnology, Bio Informatics, Bio Medical Sciences and Stem Cell Applications (B3SC) at Singapore
- Oncotarget Award by Oncotargets
- University of Konstanz (Germany) Grant
- Immunology foundation Travel Bursary Award by Immunology Foundation
- International Travel Award by Department of Biotechnology in 2016